FDA Inspection 1124229 — Novo Nordisk Pharmatech A/S

Novo Nordisk Pharmatech A/S — FEI 3008618737

The FDA completed an inspection of Novo Nordisk Pharmatech A/S on Oct 12, 2018 in Koge. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.